CONCLUSIONS
CGM feedback have the potential to offer pregnant patients a way to monitor their glucose levels during pregnancy, allowing improvement in glucose control through behavioural change and reducing the risk of developing GDM. Future trials of a larger sample size coupled with better education and guidance by health care professionals regarding the use and interpretation of the glucose sensor readings are required for better clinical outcomes.